Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancer.

•Only one quarter of IBC patients received treatment concordant with guidelines.•Patients receiving NCCN-concordant treatment had longer survival outcomes.•Non-concordant treatment was more likely in African American and Hispanic patients.•Prompt referral to medical oncology for neoadjuvant chemotherapy is crucial.